{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T16:54:46Z","timestamp":1697907286478},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1981,1,1]],"date-time":"1981-01-01T00:00:00Z","timestamp":347155200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1981]]},"DOI":"10.1007\/bf00627915","type":"journal-article","created":{"date-parts":[[2004,11,26]],"date-time":"2004-11-26T09:43:51Z","timestamp":1101462231000},"page":"169-172","source":"Crossref","is-referenced-by-count":1,"title":["Clinical pharmacology of tolmesoxide in refractory heart failure"],"prefix":"10.1007","volume":"21","author":[{"given":"C. P.","family":"O'Boyle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"McGarry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. G.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Horgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"O'Malley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0002-9149(78)90244-8","volume":"41","author":"NA Awan","year":"1978","unstructured":"Awan NA, Miller RR, Maxwell KS (1978) Development of systemic vasodilator tolerance to prazosin with chronic use of the agent in ambulatory therapy of severe congestive heart failure. Am J Cardiol 41:367","journal-title":"Am J Cardiol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/hrt.39.7.706","volume":"39","author":"K Chatterjee","year":"1977","unstructured":"Chatterjee K, Parmley W (1977) Vasodilator treatment for acute and chronic heart failure. Br Heart J 39:706?720","journal-title":"Br Heart J"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1161\/01.CIR.54.6.879","volume":"54","author":"K Chatterjee","year":"1976","unstructured":"Chatterjee K, Parmley WW, Massie B, Greenberg B, Berner J, Klausner S, Norman A (1976) Oral hydralazine therapy for chronic refractory heart failure. Circulation 54:879?883","journal-title":"Circulation"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1056\/NEJM197707072970105","volume":"297","author":"JN Cohn","year":"1977","unstructured":"Cohn JN, Franciosa JA, (1977) Vasodilator therapy of cardiac failure. N Engl J Med 297:27?31","journal-title":"N Engl J Med"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2125.1978.tb01595.x","volume":"5","author":"JG Collier","year":"1978","unstructured":"Collier JG, Lorge RE, Robinson BF (1978) Comparison of effects of tolmesoxide (R \u00d7 71107), diazoxide, hydralazine, prazosin, glyceryl trinitrate and sodium nitroprusside on forearm arteries and dorsal hand veins of man. Br J Clin Pharmacol 5:35?44","journal-title":"Br J Clin Pharmacol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1476-5381.1978.tb07780.x","volume":"63","author":"JC Doxey","year":"1978","unstructured":"Doxey JC (1978) Tolmesoxide, a drug that lowers blood pressure by a direct relaxant effect on vascular smooth muscle. Br J Pharmacol 63:111?118","journal-title":"Br J Pharmacol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1161\/01.CIR.50.5.1020","volume":"50","author":"JA Franciosa","year":"1974","unstructured":"Franciosa JA, Mikulic E, Cohn JN et al. (1974) Haemodynamic effects of chewable isosorbide dinitrate in patients with congestive heart failure. Circulation 50:1020?1024","journal-title":"Circulation"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"388","DOI":"10.7326\/0003-4819-86-4-388","volume":"86","author":"JA Franciosa","year":"1977","unstructured":"Franciosa JA, Pierpont G, Cohn JN (1977) Haemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients. Ann Intern Med 86:388?393","journal-title":"Ann Intern Med"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1056\/NEJM197409192911201","volume":"291","author":"NH Guiha","year":"1974","unstructured":"Guiha NH, Cohn JN, Mikulic E et al. (1974) Treatment of refractory heart failure with infusion of nitroprusside. N Engl J Med 291:587?592","journal-title":"N Engl J Med"},{"key":"CR10","unstructured":"O'Boyle CP, Laher M, O'Brien ET, O'Malley K, Kelly JG (1981) The clinical pharmacology of tolmesoxide, a new vasodilator antihypertensive agent. Eur J Clin Pharmacol 21 (in press)"},{"key":"CR11","unstructured":"O'Malley K, O'Boyle C, McGarry K, O'Brien ET (1980) Vasodilator and ?-adrenoceptor blocking drugs in the treatment of hypertension. The Royal Society of Medicine, Int., Congress & Symposium Series. No.26:73?81"},{"key":"CR12","unstructured":"Piafsky KM, Sitar DS, Rangno RE, Ogilvie RI (1974) Disposition of theophylline in acute pulmonary oedema. Clin Res 22:726A"},{"issue":"Suppl II","key":"CR13","first-page":"215","volume":"54","author":"G Pierpont","year":"1976","unstructured":"Pierpont G, Franciosa JA, Cohn JN (1976) Equivalent haemodynamic effects of nitroprusside and hydralazine ? nitrate combination in left ventricular failure. Circulation 54 (Suppl II):215","journal-title":"Circulation"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1161\/01.CIR.43.2.205","volume":"43","author":"RE Stenson","year":"1971","unstructured":"Stenson RE, Constantino RE, Harrison DC (1971) Inter-relationship of hepatic blood flow, cardiac output and blood levels of lidocaine in man. Circulation 43:205?211","journal-title":"Circulation"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00627915.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00627915\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00627915","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T19:08:16Z","timestamp":1554836896000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00627915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1981]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1981]]}},"alternative-id":["BF00627915"],"URL":"https:\/\/doi.org\/10.1007\/bf00627915","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1981]]}}}